课题基金 / 基金详情

Administrative Core - New therapeutic vulnerabilities in breast cancer

Administrative Core - New therapeutic vulnerabilities in breast cancer
行政核心 - 乳腺癌的新治疗漏洞
批准号:
10627981
负责人:
KORNELIA POLYAK
金额:
$11.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-11 至 2025-05-31

项目摘要

项目成果

KORNELIA POLYAK的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 行政核心的目标是为计划项目赠款提供行政支持, 积极促进项目之间的协同作用,并促进有效利用核心资源。行政核心 主要研究者办公室的管理人员将负责将计划资金分配给 其他参与项目和核心领导人。此外,行政核心管理员将 负责计划和组织月度计划项目会议和年度计划 撤退。这包括为每月会议安排发言人和组织通宵会议 住宿、膳食后勤以及PPG和IAB的科学报告议程(内部 咨询委员会)成员实验室,以及EAB(外部咨询委员会)的成员参加年度务虚会。 行政核心管理员还将负责与IEB和EAB成员的沟通 包括安排会议和分发材料,以审查这些会议,以及收集 向EAB成员提供反馈和分发酬金。
英文摘要
Project Summary/Abstract The goal of the Administrative Core is to provide administrative support to the Program Project Grant, and to actively promote synergy among projects and to facilitate the efficient use of the Cores. The Administrative Core Administrator in the office of the Principal Investigator will be responsible for distributing the Program funds to other participating Project and Core Leaders. In addition, the Administrative Core administrator will be responsible for scheduling and organizing the monthly Program Project meetings and the annual Program Retreats. This includes the scheduling of speakers for the monthly meetings and organizing overnight accommodations, the logistics of meals, and agenda of scientific presentations from PPG and IAB (Internal Advisory Board) member labs, as well as members of the EAB (External Advisory Board) for the annual retreat. The Administrative Core administrator will also be responsible for communication with IEB and EAB members including scheduling meetings and distributing material to be reviewed for these meetings as well as collecting feedback and distributing honoraria to EAB members.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core - New therapeutic vulnerabilities in breast cancer
  • 批准号:
    10261469
  • 项目类别:
  • 资助金额:
    $11.58万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
Epigenetic mechanisms of therapeutic resistance
  • 批准号:
    10627962
  • 项目类别:
  • 资助金额:
    $35.88万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
Epigenetic mechanisms of therapeutic resistance
  • 批准号:
    10434103
  • 项目类别:
  • 资助金额:
    $35.88万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
New therapeutic vulnerabilities in breast cancer
  • 批准号:
    10434102
  • 项目类别:
  • 资助金额:
    $171.86万
  • 财政年份:
    2020
  • 负责人:
    KORNELIA POLYAK
  • 依托单位:
国内基金
海外基金
αβ珠蛋白融合基因—Lepore-Boston的结构及表达调控
  • 批准号:
    39370398
  • 项目类别:
    面上项目
  • 资助金额:
    7.0万元
  • 批准年份:
    1993
  • 负责人:
    朱定尔
  • 依托单位: